Drug firm Abbott India today reported 20.68 per cent rise in its standalone net profit to Rs 64.53 crore for the third quarter ended December 31, 2014-15.
The company had posted a net profit of Rs 53.46 crore for the October-December period of the 2013-14 fiscal.
Standalone total income from operations of the company also rose to Rs 573.54 crore for the third quarter, as against Rs 479.94 crore in the same period year ago, Abbott India said in a filing to BSE.
Abbott India scrip today closed at Rs 3,984.75, up 0.79 per cent, on the BSE.
